Ethical Gmbh,
OBJECTIVE This multicenter, treat-to-target, phase 3 trial evaluated the efficacy and safety of fast-acting insulin aspart (faste…
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group…
Overview of attention for article published in Diabetes Care, March 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Mentioned by
- news
- 3 news outlets
- policy
- 1 policy source
- 21 X users
- 1 Facebook page
- googleplus
- 2 Google+ users
- guideline
- 6 clinical guideline sources
Readers on
- mendeley
- 147 Mendeley
- citeulike
- 1 CiteULike